Active	Status	Sponsor type	Region	Phase	Filter
174 Active 12 Inactive 186 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
PF-06664178 / Pfizer
No trials found
datopotamab deruxtecan (DS-1062a) / Daiichi Sankyo, AstraZeneca
No trials found
BAT8003 / Bio-Thera Solutions
No trials found
anti TROP-2 antibody therapeutic / Roche
No trials found
sacituzumab tirumotecan (MK-2870) / Merck (MSD)
No trials found
JS108 / Shanghai Junshi Biosci, Hangzhou DAC Biotech
No trials found
FDA018 / Shanghai Fudan-Zhangjiang
No trials found
ESG401 / Escugen Biotechnology, Sorrento
No trials found
BHV-1510 / Biohaven
No trials found
GQ1003 / GeneQuantum Healthcare, Samsung
No trials found
BL-M02D1 / Biokin Pharma
No trials found
SHR-A1921 / Jiangsu Hengrui Pharma
No trials found
SHR-A2009 / Jiangsu Hengrui Pharma
No trials found
BSI-04702 / OBI Pharma
No trials found
PBX-001 / PinotBio
No trials found
DXC003 / Hangzhou DAC Biotech
No trials found
BIO-106 / BiOneCure
No trials found
Undisclosed Trop2-targeted ETB / Molecular Templates
No trials found
Undisclosed TROP-2 ADC / Fontacea
No trials found
LCB84 / J&J
No trials found
BNT325 / BioNTech
No trials found
BAT8008 / Bio-Thera Solutions
No trials found
YH012 / Biocytogen, Radiance Biopharma
No trials found
MHB036C / Minghui Pharma
No trials found